Early detection and interception of pancreatic ductal adenocarcinoma (PDAC) remain the only realistic strategies to reduce ...

Influence of underlying liver disease on response to sorafenib in patients with advanced hepatocellular carcinoma (HCC). Methods: An epidemiologic questionnaire was administered to patients (pts) with ...

An intraductal papillary mucinous neoplasm (IPMN) is a benign or noncancerous cyst in the ducts of the pancreas. The cysts are sometimes precancerous, which means they may lead to pancreatic cancer.

IPMN tumors are being recognized with increasing frequency and appear to have a better prognosis than adenocarcinoma of the pancreas. This report highlights the increased risk for other benign or ...

“The sensitivity of current factors used to predict malignant intraductal papillary mucinous neoplasm (IPMN) is not high,” says Masao Tanaka (Kyushu University, Japan). “Thus, more sensitive factors ...

Researchers report two breakthroughs in understanding pancreatic cancer: the development of the first mouse model that simulates a precursor lesion called intraductal papillary mucinous neoplasia ...

The majority of pancreatic cancers are thought to evolve through a series of hyperplastic and dysplastic ductal lesions termed PanIN. Normal ductal epithelium progresses to invasive adenocarcinomas ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — If a branch duct-intraductal papillary mucinous neoplasm grows at a rate of 5 mm or more annually, ...

Sonography in a 75-year-old man with cingulate upper abdominal pain showed an greatly enlarged pancreas with multiple cystic elements. Magnetic resonance cholangiopancreatography (MRCP) identified a ...

Dear Dr. Roach: Are you aware of the possibility of pancreatitis resulting from long-term vitamin D2 supplementation? I was diagnosed with IPMN with chronic pancreatitis after being on 50,000 IU of ...